tradingkey.logo
tradingkey.logo
Pesquisar

Labcorp Holdings Inc

LH
Adicionar à lista de desejos
271.470USD
0.0000.00%
Fechamento 06/26, 16:00ETCotações atrasadas em 15 min
22.26BValor de mercado
23.89P/L TTM

Mais detalhes de Labcorp Holdings Inc Empresa

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Informações de Labcorp Holdings Inc

Código da empresaLH
Nome da EmpresaLabcorp Holdings Inc
Data de listagemApr 24, 1991
CEOSchechter (Adam H)
Número de funcionários70000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 24
Endereço358 S Main St
CidadeBURLINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal27215
Telefone13362291127
Sitehttps://www.labcorp.com/
Código da empresaLH
Data de listagemApr 24, 1991
CEOSchechter (Adam H)

Executivos da empresa Labcorp Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.85K
+2.92%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
7.88K
+27.39%
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ms. Anita Z. Graham
Ms. Anita Z. Graham
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
5.18K
+71.84%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Labcorp Holdings Inc?

Os cinco principais acionistas de Labcorp Holdings Inc são: Mr. Adam H. Schechter

Quantas instituições possuem ações da Labcorp Holdings Inc (LH)?

Em 2026Q1, 1855 instituições possuíam ações da Labcorp Holdings Inc, com valor de mercado aproximado de 88.74M, representando 108.22% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 5570263.00.
KeyAI